Neurological Surgery · Modesto, CA
NPI
1043268857
Since 2006
Specialty
Neurological Surgery
Code 207T00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 524-1211
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
30,221 services
Medicare patients, 2024
659
Average age 72
Drug cost, 2024
$2.3M
5,731 prescriptions
Company payments, 2025
$4,287
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bettina P Harner was code J0585 (injection, onabotulinumtoxina, 1 unit), 28,300 times for 43 patients. In total Bettina P Harner billed 30,221 services in 29 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 28,300 | 43 | $4.90 | $139K |
| 99214 Office E&M - Established | Office | 792 | 403 | $95.19 | $75K |
| 99215 Office E&M - Established | Office | 129 | 102 | $138.52 | $18K |
| 99204 Office E&M - New | Office | 119 | 118 | $117.27 | $14K |
| 95885 Electrical Nerve Conductivity | Office | 112 | 98 | $48.91 | $5,478 |
| 64615 Musculoskeletal | Office | 102 | 32 | $120.23 | $12K |
| 95909 Electrical Nerve Conductivity | Office | 62 | 62 | $102.20 | $6,336 |
| 99205 Office E&M - New | Office | 60 | 60 | $165.21 | $9,913 |
| 99213 Office E&M - Established | Office | 51 | 49 | $58.19 | $2,968 |
| 95908 Electrical Nerve Conductivity | Office | 34 | 33 | $82.06 | $2,790 |
| 95816 Neurologic | Office | 27 | 27 | $321.10 | $8,670 |
| 95886 Electrical Nerve Conductivity | Office | 25 | 25 | $78.30 | $1,958 |
| 95910 Electrical Nerve Conductivity | Office | 13 | 13 | $132.56 | $1,723 |
By year: 2022 $298K for 26,986 services; 2023 $270K for 25,365 services; 2024 $319K for 30,221 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bettina P Harner prescribed most often to Medicare patients was Memantine Hcl, with 686 prescriptions and refills. In total Bettina P Harner wrote 5,731 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 686 | 1,218 | 167 | $25K |
| Gabapentin Generic | 673 | 1,091 | 141 | $15K |
| Donepezil Hcl Generic | 469 | 910 | 133 | $3,591 |
| Levetiracetam Generic | 295 | 571 | 71 | $15K |
| Lamotrigine Generic | 229 | 359 | 41 | $3,770 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 172 | 347 | 46 | $4,252 |
| Topiramate Generic | 170 | 320 | 42 | $1,880 |
| Pregabalin Generic | 170 | 196 | 30 | $3,392 |
| Duloxetine Hcl Generic | 158 | 319 | 37 | $3,978 |
| Nurtec Odt Rimegepant Sulfate | 150 | 152 | 26 | $216K |
| Nortriptyline Hcl Generic | 139 | 207 | 41 | $2,388 |
| Lacosamide Generic | 103 | 124 | 18 | $17K |
| Primidone Generic | 96 | 173 | 27 | $2,144 |
| Quetiapine Fumarate Generic | 85 | 119 | 21 | $1,494 |
| Xcopri Cenobamate | 82 | 82 | Under 11 | $99K |
Brand drugs: 618 claims; generic drugs: 5,088 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bettina P Harner $4,287 ($4,287 in general payments such as food, travel and fees) from 16 companies. The largest payer was LivaNova USA, Inc. with $2,262.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 7 | $2,262 |
| Abbvie Inc. ABBV | 21 | $452 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $370 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 2 | $175 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $138 |
| Axsome Therapeutics, Inc. AXSM | 5 | $130 |
| Eisai Inc. 4523.T | 3 | $112 |
| UCB, Inc. UCB.BR | 4 | $91.52 |
| CSL Behring CSL.AX | 1 | $84.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.